Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Secondary leukemia after severe aplastic anemia.

A Tichelli1, A Gratwohl, A Würsch

  • 1Department of Internal Medicine, Kantonsspital, Basel, Switzerland.

Blut
|February 1, 1988
PubMed
Summary

This case study shows that chemotherapy can effectively treat secondary acute myeloid leukemia (AML) in patients previously treated for severe aplastic anemia (SAA). It also demonstrates bone marrow recovery potential after intensive treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants.

Leukemia·2017
Same author

Latin America: the next region for haematopoietic transplant progress.

Bone marrow transplantation·2017
Same author

Alloreactivity: the Janus-face of hematopoietic stem cell transplantation.

Leukemia·2017
Same author

Latin America: the next region for haematopoietic transplant progress.

Bone marrow transplantation·2017
Same author

The EBMT-ELN working group recommendations on the prophylaxis and treatment of GvHD: a change-control analysis.

Bone marrow transplantation·2016
Same author

Allogeneic Bone Marrow Transplantation in Chronic Lymphocytic Leukemia: 17 Cases. Report of the EBMT.

Leukemia & lymphoma·2016

Area of Science:

  • Hematology
  • Oncology

Background:

  • Severe aplastic anemia (SAA) is a rare bone marrow failure disorder.
  • Antilymphocyte globulin (ALG) is a common treatment for SAA.
  • Secondary malignancies can arise after SAA treatment.

Observation:

  • A patient with SAA treated with ALG developed myelodysplastic syndrome (MDS) and subsequently acute myeloid leukemia (AML).
  • The patient achieved remission of SAA and later AML after chemotherapy.
  • Morphological changes in bone marrow during SAA remission may indicate future leukemia risk.

Findings:

  • Successful chemotherapy treatment of secondary AML in an ex-aplastic marrow.
  • Demonstration of bone marrow's capacity for recovery from chemotherapy-induced aplasia.
  • Early morphological anomalies in SAA remission can predict later leukemic transformation.

Related Experiment Videos

Implications:

  • Chemotherapy is a feasible treatment option for secondary leukemia post-SAA.
  • Ex-aplastic bone marrow can recover significantly after intensive chemotherapy.
  • Monitoring for morphological changes in SAA remission is crucial for early AML detection.